Sea Mild Biotechnology Co., Ltd.(TW:7516)
NT$7.65+0.02 (+0.26%)
TW:7516
Sea Mild Biotechnology Co., Ltd. financials statements
NT$7.65
At close:+0.02 (+0.26%)
Sea Mild Biotechnology Co., Ltd. (7516) Ratios
Sea Mild Biotechnology Co., Ltd. Ratios
TW:7516's free cash flow for Q2 2026 was NT$-20.40M. For the 2026 fiscal year, TW:7516's free cash flow was decreased by NT$-10.83M and operating cash flow was NT$-9.57M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.45 | 1.44 | 1.33 | 1.51 | 1.74 |
| Quick Ratio | 1.07 | 1.06 | 1.07 | 1.31 | 1.41 |
| Cash Ratio | 0.50 | 0.55 | 0.41 | 0.50 | 0.60 |
| Solvency Ratio | 0.15 | 0.33 | 0.17 | -0.07 | -0.38 |
| Operating Cash Flow Ratio | 0.04 | 0.23 | 0.08 | 0.16 | -0.19 |
| Short-Term Operating Cash Flow Coverage | 0.08 | 0.58 | 0.25 | 1.64 | -1.92 |
| Net Current Asset Value | NT$ 42.72M | NT$ 62.70M | NT$ 30.88M | NT$ 30.19M | NT$ 30.70M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.38 | 0.27 | 0.29 | 0.19 | 0.19 |
| Debt-to-Equity Ratio | 1.11 | 0.68 | 0.78 | 0.47 | 0.37 |
| Debt-to-Capital Ratio | 0.53 | 0.41 | 0.44 | 0.32 | 0.27 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.03 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 2.95 | 2.50 | 2.70 | 2.45 | 1.96 |
| Debt Service Coverage Ratio | 0.34 | 0.86 | 0.59 | -0.64 | -4.18 |
| Interest Coverage Ratio | 3.01 | 17.71 | 5.01 | -17.59 | -38.45 |
| Debt to Market Cap | 0.55 | 0.26 | 0.17 | 0.11 | 0.04 |
| Interest Debt Per Share | 7.01 | 3.69 | 2.90 | 1.61 | 1.68 |
| Net Debt to EBITDA | 1.09 | -0.24 | 0.39 | 1.82 | 0.36 |
| Profitability Margins | |||||
| Gross Profit Margin | 26.09% | 28.63% | 21.93% | 13.85% | 7.91% |
| EBIT Margin | 2.17% | 10.72% | 2.76% | -10.27% | -25.13% |
| EBITDA Margin | 9.01% | 16.70% | 8.40% | -2.78% | -12.41% |
| Operating Profit Margin | 2.17% | 6.99% | 1.88% | -5.91% | -19.53% |
| Pretax Profit Margin | 2.57% | 10.33% | 2.39% | -10.60% | -25.64% |
| Net Profit Margin | 2.40% | 10.03% | 2.41% | -10.55% | -31.77% |
| Continuous Operations Profit Margin | 2.40% | 10.03% | 2.41% | -10.55% | -31.77% |
| Net Income Per EBT | 93.50% | 97.12% | 100.90% | 99.52% | 123.95% |
| EBT Per EBIT | 118.62% | 147.85% | 126.88% | 179.31% | 131.28% |
| Return on Assets (ROA) | 2.52% | 12.49% | 3.25% | -13.56% | -30.94% |
| Return on Equity (ROE) | 7.43% | 31.24% | 8.79% | -33.16% | -60.65% |
| Return on Capital Employed (ROCE) | 5.00% | 20.95% | 6.30% | -15.73% | -31.02% |
| Return on Invested Capital (ROIC) | 2.97% | 12.55% | 3.85% | -12.57% | -27.24% |
| Return on Tangible Assets | 2.52% | 12.93% | 3.25% | -13.59% | -31.07% |
| Earnings Yield | 4.55% | 13.47% | 2.86% | -29.93% | -33.70% |
| Efficiency Ratios | |||||
| Receivables Turnover | 4.29 | 5.01 | 4.41 | 3.51 | 3.24 |
| Payables Turnover | 4.19 | 4.32 | 5.08 | 4.21 | 4.88 |
| Inventory Turnover | 3.71 | 3.92 | 6.97 | 10.41 | 7.14 |
| Fixed Asset Turnover | 5.80 | 12.81 | 11.08 | 7.43 | 3.79 |
| Asset Turnover | 1.05 | 1.24 | 1.35 | 1.29 | 0.97 |
| Working Capital Turnover Ratio | 4.66 | 6.14 | 6.50 | 4.51 | 2.77 |
| Cash Conversion Cycle | 96.43 | 81.38 | 63.22 | 52.16 | 88.90 |
| Days of Sales Outstanding | 84.99 | 72.83 | 82.74 | 103.87 | 112.58 |
| Days of Inventory Outstanding | 98.48 | 93.06 | 52.40 | 35.05 | 51.14 |
| Days of Payables Outstanding | 87.04 | 84.51 | 71.92 | 86.77 | 74.83 |
| Operating Cycle | 183.47 | 165.89 | 135.14 | 138.93 | 163.73 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.38 | 1.77 | 0.46 | 0.68 | -0.64 |
| Free Cash Flow Per Share | -0.46 | 1.18 | 0.39 | 0.67 | -0.82 |
| Dividend Paid and CapEx Coverage Ratio | 0.46 | 3.00 | 7.09 | 40.42 | -3.65 |
| Capital Expenditure Coverage Ratio | 0.46 | 3.00 | 7.09 | 40.42 | -3.65 |
| Operating Cash Flow Coverage Ratio | 0.06 | 0.49 | 0.16 | 0.43 | -0.39 |
| Operating Cash Flow to Sales Ratio | 0.02 | 0.11 | 0.03 | 0.07 | -0.08 |
| Free Cash Flow Yield | -4.53% | 9.61% | 3.51% | 17.99% | -10.23% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 21.96 | 7.41 | 35.00 | -3.33 | -2.96 |
| Price-to-Sales (P/S) Ratio | 0.53 | 0.74 | 0.84 | 0.35 | 0.94 |
| Price-to-Book (P/B) Ratio | 1.63 | 2.32 | 3.07 | 1.11 | 1.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -22.07 | 10.41 | 28.49 | 5.56 | -9.78 |
| Price-to-Operating Cash Flow Ratio | 26.35 | 6.93 | 24.47 | 5.42 | -12.45 |
| Price-to-Earnings Growth (PEG) Ratio | -0.30 | 0.02 | -0.27 | 0.06 | 0.50 |
| Enterprise Value Multiple | 6.95 | 4.22 | 10.41 | -10.86 | -7.24 |
| Enterprise Value | 214.04M | 224.53M | 224.67M | 61.19M | 147.13M |
| EV to EBITDA | 6.95 | 4.22 | 10.41 | -10.86 | -7.24 |
| EV to Sales | 0.63 | 0.70 | 0.87 | 0.30 | 0.90 |
| EV to Free Cash Flow | -26.18 | 9.84 | 29.60 | 4.76 | -9.31 |
| EV to Operating Cash Flow | 31.26 | 6.56 | 25.42 | 4.64 | -11.86 |
| Tangible Book Value Per Share | 6.19 | 4.85 | 3.64 | 3.32 | 4.41 |
| Shareholders’ Equity Per Share | 6.19 | 5.30 | 3.65 | 3.34 | 4.44 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.06 | 0.03 | -0.01 | 0.00 | -0.24 |
| Revenue Per Share | 19.14 | 16.51 | 13.31 | 10.50 | 8.48 |
| Net Income Per Share | 0.46 | 1.66 | 0.32 | -1.11 | -2.70 |
| Tax Burden | 0.94 | 0.97 | 1.01 | 1.00 | 1.24 |
| Interest Burden | 1.19 | 0.96 | 0.86 | 1.03 | 1.02 |
| Research & Development to Revenue | 0.02 | 0.01 | 0.01 | 0.01 | 0.03 |
| SG&A to Revenue | 0.20 | 0.20 | 0.19 | 0.22 | 0.24 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.77 | 1.04 | 1.43 | -0.62 | 0.24 |
Currency in TWD
